MTOR and chronic kidney disease: mTOR activation underlies glomerular hypertrophy in diabetic nephropathy (Nagai et al., 2005) and chronic kidney disease (Lieberthal & Levine, 2009), and mTOR inhibition prevents diabetic glomerular hypertrophy (Inoki et al., 2011).